Solvonis Therapeutics plc (LON:SVNS)
0.2960
+0.0260 (9.63%)
At close: Jan 23, 2026
Revenue by Product
Financials in millions GBX. Fiscal year is January - December.
Millions GBX. Fiscal year is Jan - Dec.
Revenue by Geography
Financials in millions GBX. Fiscal year is January - December.
Millions GBX. Fiscal year is Jan - Dec.